(Q38989368)

8 September 2017

title

Evaluation of cytokeratin-19 & cytokeratin-20 and interleukin-6 in Egyptian bladder cancer patients (English)

1 reference

8 September 2017

1 reference

Eman Mahmoud El-Salahy

series ordinal

1

1 reference

8 September 2017

publication date

1 November 2002

1 reference

8 September 2017

published in

Clinical Biochemistry

1 reference

8 September 2017

volume

35

1 reference

8 September 2017

issue

8

1 reference

8 September 2017

page(s)

607-613

1 reference

Comparison of the WHO/ISUP classification and cytokeratin 20 expression in predicting the behavior of low-grade papillary urothelial tumors. World/Health Organization/Internattional Society of Urologic Pathology

8 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Tumor suppression after tumor cell-targeted tumor necrosis factor alpha gene transfer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Detection of epithelial cancer cells in peripheral blood by reverse transcriptase-polymerase chain reaction

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Cytokine gene transfer in tumor inhibition and tumor therapy: where are we now?

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Granulocyte colony-stimulating factor gene transfer suppresses tumorigenicity of a murine adenocarcinoma in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Relationship of cytokeratin 20 and CD44 protein expression with WHO/ISUP grade in pTa and pT1 papillary urothelial neoplasia

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Keratins as biochemical markers of epithelial differentiation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Immunostaining of cytokeratin 20 in cells from voided urine for detection of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Assessing test accuracy and its clinical consequences: a primer for receiver operating characteristic curve analysis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Interleukin 7 induces CD4+ T cell-dependent tumor rejection

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Cancer patterns in the Middle East--special report from the Middle East Cancer Society.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

[Detection of urogenital malignant cells in the peripheral blood by nested RT-PCR using keratin 19 mRNA]

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Expression of cytokeratin 20 in urinary cytology of patients with bladder carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

The catalog of human cytokeratins: patterns of expression in normal epithelia, tumors and cultured cells

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

A candidate for cancer gene therapy: MIP-1 alpha gene transfer to an adenocarcinoma cell line reduced tumorigenicity and induced protective immunity in immunocompetent mice

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Interleukin-6 functions as an autocrine growth factor in human bladder carcinoma cell lines in vitro.

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Analytical and prospective evaluation of urinary cytokeratin 19 fragment in bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Biology and management of bladder cancer

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Urinary cytokeratin 20 as a marker for transitional cell carcinoma

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Murine interleukin-4 displays potent anti-tumor activity in vivo

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

The role of interleukin 12 in the immune response, disease and therapy

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

Exogenous expression of mouse interferon gamma cDNA in mouse neuroblastoma C1300 cells results in reduced tumorigenicity by augmented anti-tumor immunity

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FS0009-9120%2802%2900382-X

10.1016/S0009-9120(02)00382-X

7 January 2021

Identifiers

DOI

1 reference

8 September 2017

1 reference